A
new test may detect the presence of abnormal proteins indicative of a deadly
prion disease known as Creutzfeldt-Jakob Disease (CJD). By adapting an
established blood test for variant CJD, researchers at the University College
London say the new test accurately picks up on prions in urine, which could
enable early detection and treatment.
Modifications
to a blood test showed that it can be adapted to urine samples. The team tried
the test in 162 people – a group that consisted of healthy controls, people
with CJD, and people with other types of neurodegenerative diseases. They found
the test to have 100 percent specificity (no false positives). The sensitivity
to CJD was lower, at 40 percent. However, the team noted that this was a marked
increase from a previous test in which the sensitivity to vCJD was at 7.7
percent.
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources